Track medtech innovations from your desktop, subscribe to Innovation Hub.

Learn More
innovation hub

Medtech Innovation Tracker

Get Access

Don't wait for the next conference

100's of Vetted Start-Ups

At Your Desktop

Right Now

Track the medtech start-ups driving innovation

Data Sources

Desk Research

New companies profiled and updated real-time by in-house LSI researchers and analysts.

Conference Coverage

Coverage of the innovators, strategics & investors showcased at LSI annual Emerging Medtech Summit. Content includes recordings of the presentation and panel sessions captured at LSI’s annual Summit.

Quarterly Webinars

Deep profiles and a spotlight on the hottest innovators identified by LSI analysts. This content is delivered via quarterly webinars.

What’s Included


Company Profiles




CEO Pitches


Spotlight Events


Medtech Summit

Database Preview

emt-slider/1-db.png emt-slider/1-ems.jpeg emt-slider/2-db.png emt-slider/2-ems.jpeg emt-slider/3-db.png emt-slider/3-ems.jpeg emt-slider/4-db.png emt-slider/4-ems.jpeg emt-slider/5-db.png emt-slider/5-ems.jpeg emt-slider/6-db.png emt-slider/6-ems.jpeg emt-slider/7-ems.jpeg

Sample Profile

nView medical

Next generation medical imaging technology to enable minimally invasive surgical procedures
Key Executive

Cristian Atria
Founder & CEO


City: Salt Lake City

State: UT

Country: United States

Company Type: Imaging

Year Established: 2012

Additional Details: The company has received $2.8M non-dilutive funding from NSF, NIH, UTAH and $2.6M from investors with seed round led by Fusion Fund. The company has lined up customers with champions in top 10 pediatric hospitals, 2 IRBs in process and pilots planned in 1H 2020. Core patents are issued with 3 in process.

Company Details
Company Status

Latest Round: Series A

Amount Raised: $1,200,000.00

Regulatory/Development Status: FDA 510(k) Cleared. Broad indication in adult and pediatrics.

Revenue (Past Year): Private

Sales Projection (5 Years from Now): $22M in 2022

Additional details: nView medical is a surgical company with breakthrough technology. Its first product, nView s1, is FDA cleared with four patents issued or filed. By leveraging AI and GPU/cloud computing nView s1 provides 3D images faster, with less radiation. Pilots are expected in 1H 2020. nView is seeking an $8M series-A raise in 1H 2020. The company strategy is to win in the pediatric beachhead before expanding into the adult market with offerings in imaging, navigation and robotics. nView targets an exit to strategics, with its closest comparable being Mobius imaging and Cardan robotics sold to Stryker in 2019 for $500M.

Recently Covered Companies